N/A
Completed N=24
SMS System for Patients With Uncontrolled Hypertension
Source: ClinicalTrials.gov NCT03596242 ↗Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Number of Participants Screened — 12; 12 participants
Summary
This is a pilot study to determine the potential of utilizing Short Message Service (SMS) messaging to improve health outcomes for patients with uncontrolled hypertension receiving care from the Outpatient Internal Medicine Clinic at Wake Forest Baptist Hospital.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Screened |
12; 12 | — |
| PRIMARY Number of Subjects Enrolled |
12; 12 | — |
| PRIMARY Number of Subjects Who Refuse Participation |
0; 0 | — |
| PRIMARY Number of Subjects Excluded Without SMS Capability |
0; 0 | — |
| PRIMARY Proportion of Participants Continuing myHealth |
0; 0 | — |
| PRIMARY Number of Participants Who Responded to SMS With At Least One Home BP Measurement |
8 | — |
| PRIMARY SMS Participation |
12 | — |
| PRIMARY System Usability Scale (SUS) |
92.25 | — |
| SECONDARY Medication Adherence |
— | — |
| SECONDARY Medication Adherence Questionnaire |
2.17; 2.02; 0.93; 1.8 | — |
| SECONDARY Monitoring of SBP |
15; 13 | — |
| SECONDARY Monitoring of DBP |
10; 8 | — |
| SECONDARY Initial and Follow up BP in Office |
10; 10; 10; 10 | — |
| SECONDARY Number of Participants Considered No-Shows at Clinic Visits |
1; 1 | — |
| SECONDARY Coordinator Time |
— | — |
Eligibility Criteria
Inclusion Criteria
- Patients who have been diagnosed with hypertension
- 18 and older
- stage 2 hypertension or greater systolic blood pressure [(SBP)>140 and diastolic blood pressure (DBP) >90] who are receiving antihypertensive treatment.
Exclusion Criteria
- Pregnancy
- end-stage renal disease (on hemodialysis or peritoneal dialysis)
- hospice or nursing home care
- dementia
- Patients who do not have a phone with Short Message Service (SMS) capabilities will also be excluded.
Data sourced from ClinicalTrials.gov (NCT03596242). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.